Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Johnson and Johnson
McKinsey
McKesson
Cipla
Accenture
Cantor Fitzgerald
Citi

Generated: July 17, 2018

DrugPatentWatch Database Preview

Technetium tc-99m medronate kit - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for technetium tc-99m medronate kit and what is the scope of technetium tc-99m medronate kit patent protection?

Technetium tc-99m medronate kit
is the generic ingredient in five branded drugs marketed by Ge Healthcare, Pharmalucence, and Cardinal Health 414, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m medronate kit. One supplier is listed for this compound.
Summary for technetium tc-99m medronate kit
Pharmacology for technetium tc-99m medronate kit

US Patents and Regulatory Information for technetium tc-99m medronate kit

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmalucence CIS-MDP technetium tc-99m medronate kit INJECTABLE;INJECTION 018124-001 Approved Prior to Jan 1, 1982 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ge Healthcare TECHNETIUM TC 99M MPI MDP technetium tc-99m medronate kit INJECTABLE;INJECTION 018141-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ge Healthcare TECHNETIUM TC 99M MPI MDP technetium tc-99m medronate kit INJECTABLE;INJECTION 018141-002 Jun 12, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ge Healthcare AMERSCAN MDP KIT technetium tc-99m medronate kit INJECTABLE;INJECTION 018335-001 Aug 5, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Boehringer Ingelheim
Baxter
Johnson and Johnson
Cantor Fitzgerald
QuintilesIMS
Dow
Moodys
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.